MANAGED ACCOUNT ADVISORS LLC - GW PHARMACEUTICALS PLC ownership

GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 106 filers reported holding GW PHARMACEUTICALS PLC in Q2 2015. The put-call ratio across all filers is 1.27 and the average weighting 0.2%.

Quarter-by-quarter ownership
MANAGED ACCOUNT ADVISORS LLC ownership history of GW PHARMACEUTICALS PLC
ValueSharesWeighting
Q2 2015$51,899,000
+104.7%
422,494
+51.8%
0.04%
+95.5%
Q1 2015$25,357,000
+650.7%
278,254
+457.5%
0.02%
+633.3%
Q4 2014$3,378,000
-0.4%
49,913
+19.0%
0.00%
-25.0%
Q3 2014$3,391,00041,9410.00%
Other shareholders
GW PHARMACEUTICALS PLC shareholders Q2 2015
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 450,000$55,224,0004.41%
Parkman Healthcare Partners LLC 119,778$14,699,0004.14%
Sio Capital Management, LLC 94,984$11,656,0003.40%
Tamarack Advisers, LP 90,000$11,045,0003.08%
Copernicus Capital Management, LLC 22,000$2,700,0002.96%
Integral Health Asset Management, LLC 75,000$9,204,0002.76%
ETF MANAGERS GROUP, LLC 480,145$58,923,0002.09%
AdvisorShares Investments LLC 29,758$3,652,0001.55%
Redwood Investments, LLC 130,444$16,008,0001.42%
CLOUGH CAPITAL PARTNERS L P 100,746$12,364,0001.21%
View complete list of GW PHARMACEUTICALS PLC shareholders